semaglutide and vision loss linked to increased risk of in diabetes patients Northeast Ohio woman reports vision

Description

JD: Conceptualization, Methodology, Supervision, Writingoriginal draft, Writingreview and editing

Related: To Tackle Our Obesity Crisis, Experts Say Everything We Do Must Change GLP-1 is a natural hormone in the body that slows digestion, controls appetite, and regulates blood sugar

Both are injections given with strict medical oversight, but there are some differences between them: Semaglutide: Semaglutide is the GLP-1 receptor agonist behind brand names like Ozempic and Wegovy

Diabet Med 2017 Jul

The SOUL cardiovascular outcomes trial (CVOT) demonstrated a 14% relative reduction in risk of MACE in patients treated with Rybelsus 14 mg orally once daily for approximately 5 years compared to those who received placebo